Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FY.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.413EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.5.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.268EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.409EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.587EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.232EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.60EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CD.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DE.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.333EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.397EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.277EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.294EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.81EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FG.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.426EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.399EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.337EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.539EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.54EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.164EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.392EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BG.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JF.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.572EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.397EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.3 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.523EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.116 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.38 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.595.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.340EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used